Yang Song, MBBS^1*, Jin Seok Kim, MD, PhD^2*, CS Chim, MD, PhD, BMBS^3*, Je-Jung Lee^4*, Sung-Soo Yoon, MD, PhD⁵, Soo Chin Ng, FRCP⁶, Gin Gin Gan^7*, Hiroshi Handa⁸, Wei-Ying Jen, MD, FRCPath, MA^1*, Xinhua Li^9*, Yogesh Mahadev Pokharkar^9*, Brian GM Durie, MD¹⁰ and Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP¹

¹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
²Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of (South)
³Comprehensive Oncology Centre, 3/F, Li Shu Fan Block, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong, China
⁴Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
⁵Department of Hemato-Oncology, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Subang Jaya Medical Center, Petaling Jaya, Malaysia
⁷University of Malaya, Kuala Lumpur, Malaysia
⁸Department of Hematology, Gunma University Hospital, Maebashi, Gunma, Japan
⁹Singapore Clinical Research Institute, Singapore, Singapore
¹⁰Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

Ajai Chari, MD^1*, Albert Oriol, MD^2*, Amrita Krishnan, MD³, Maria Del Carmen Martinez Chamorro^4*, Luciano Costa, MD, PhD⁵, Maria Victoria Mateos, MD, PhD⁶, Monique C Minnema^7*, Michela Campagna, PhD^8*, Tara J Masterson, MS^9*, Brandi W Hilder, PhD⁹, Jaszianne Tolbert, MD¹⁰, Thomas Renaud, MD¹⁰, M. Damiette Smit^11*, Swarna Ramanjulu^9* and Paula Rodríguez Otero^12*

¹at the time that the work was performed, Mount Sinai School of Medicine, New York, NY
²Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
³Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Irvine, CA
⁴University Hospital Quirónsalud, Pozuelo de Alarcón, Madrid, Spain
⁵University of Alabama at Birmingham, Birmingham, AL
⁶University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
⁷University Medical Center Utrecht, Utrecht, Netherlands
⁸Janssen Research & Development, Madrid, Spain
⁹Janssen Research & Development, Spring House, PA
¹⁰Janssen Research & Development, Raritan, NJ
¹¹Janssen Biologics BV, Leiden, Netherlands
¹²Clínica Universidad de Navarra, Pamplona, Spain

Hang Quach, MD, FRACP, FRCPA, MBBS¹, Doug Sborov², Dickran Kazandjian, MD³, Andrew Spencer, MBBS, MD, FRACP, FRCPA^4*, Michael Low^5*, Susan Bal, MD⁶, Natalie S. Callander, MD⁷, Huan Cheng^8*, Sheel Patel^8*, Rocco J. Crescenzo, DO^8*, Amit Agarwal^9* and Binod Dhakal, MBBS¹⁰

¹St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
²University of Utah School of Medicine, Salt Lake City, UT
³University of Miami, Coral Gables, FL
⁴Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
⁵Monash Haematology, Monash University, Clayton University, Victoria, Australia
⁶University of Alabama at Birmingham, Birmingham, AL
⁷UW Health University Hospital, Madison, WI
⁸BeiGene USA, Inc, San Mateo, CA
⁹BeiGene, San Mateo, CA
¹⁰Medical College of Wisconsin, Milwaukee, WI

Sumit Madan, MD¹, Caitlin L. Costello, MD², Brea Lipe, MD³, Andrew J. Cowan, MD^4,5,6,7,8,9, Eva Medvedova, MD^10*, Jens Hillengass, MD, PhD¹¹, P. Leif Bergsagel, MD¹², Xavier Leleu, MD¹³, Cyrille Touzeau, MD, PhD^14*, Daniel Morillo, MD^15*, Albert Oriol^16*, Raya Mawad, MD¹⁷, Henning Schade, MD^18*, Salomon Manier, MD, PhD¹⁹, Yifah Yaron, MD, PhD^20*, Banmeet Anand, PhD^20* and Al-Ola Abdallah, MD²¹

¹Banner MD Anderson Cancer Center, Gilbert, AZ
²Moores Cancer Center at University of California San Diego, San Diego, CA
³University of Rochester Medical Center, Rochester, NY
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
⁷University of Washington/Fred Hutchinson Cancer Center, Seattle, WA
⁸University of Washington, Seattle, WA
⁹Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹¹Roswell Park, Buffalo, NY
¹²Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
¹³Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
¹⁴Centre Hospitalier Universitaire de Nantes, Nantes, France
¹⁵Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁶Hematology Department, Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain
¹⁷Fred Hutchinson Cancer Center, Seattle, WA
¹⁸Colorado Blood Cancer Institute, Denver, CO
¹⁹CHU Lille, Université de Lille, Lille, France
²⁰Harpoon Therapeutics, South San Francisco, CA
²¹University of Kansas Medical Center, Kansas City, KS

Paul G. Richardson, MD¹, Irwindeep Sandhu², Craig C. Hofmeister, MD³, Robert Z. Orlowski, MD, PhD⁴, Darrell White⁵, Angelo Belotti, MD^6*, Charlotte Toftmann Hansen^7*, Noopur S. Raje^8*, Tracy T. Chow^9*, Zehua Zhou^9*, Tiziana Civardi^10*, Phillip Koo^9*, Yue Zhu^9*, Jessica Katz⁹ and Albert Oriol^11*

¹Dana-Farber Cancer Institute, Boston, MA
²Cross Cancer Institute, Edmonton, AB, Canada
³Winship Cancer Institute of Emory University, Atlanta
⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁶Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
⁷Odense University Hospital, Odense, Denmark
⁸Massachusetts General Hospital, Boston, MA
⁹Bristol Myers Squibb, Princeton, NJ
¹⁰Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹¹Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Jeffrey V Matous, MD¹, Noa Biran, MD², Aurore Perrot, MD, PhD³, Jésus G Berdeja, MD⁴, Kathleen Dorritie, MD⁵, Janine Van Elssen, MD, PhD^6*, Emma Searle, MD^7*, Cyrille Touzeau, MD, PhD^8*, Sébastien Anguille^9*, Deeksha Vishwamitra, PhD¹⁰, Ashley Nguyen^10*, Debopriya Ghosh^11*, Elizabeth Shearin, PharmD^12*, Katherine Thornton^10*, Damiette Smit^13* and Hang Quach, MD, FRACP, FRCPA, MBBS¹⁴

¹Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
²Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
³Service Hematologie, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
⁴Sarah Cannon Research Institute, Nashville, TN
⁵UPMC Hillman Cancer Center, Pittsburgh, PA
⁶Maastricht University Medical Center, Maastricht, Netherlands
⁷The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
⁸Centre Hospitalier Universitaire de Nantes, Nantes, France
⁹Antwerp University Hospital, Edegem, Belgium
¹⁰Janssen Research & Development, Spring House, PA
¹¹Janssen Research & Development, Bridgewater, NJ
¹²Janssen Research and Development, Spring House, PA
¹³Janssen Biologics Europe, Leiden, Netherlands
¹⁴St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia